Drawing for MAK-METICS

USPTO serial 99871125

MAK-METICS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with MAK-METICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003Facial lotion; Night cream; Anti-aging cream; Eye cream; Anti-wrinkle cream; Facial cleansing cream; Body creams; Face creams; Facial creams; Skin creams; Anti-wrinkle creams; Anti-aging creams; Face and body creams; Make-up removing creams; Cosmetic creams for skin care; Face and body beauty creams; Skin creams in liquid and solid; Non-medicated skin care creams and lotions; Make-up removing milk, gel, lotions and creams; Age spot reducing creams for cosmetic use; Skin and body topical lotions, creams and oils for cosmetic useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 8, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 8, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance